Zymostenol
| Names | |
|---|---|
| IUPAC name
(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
| |
| Other names
(5α)-cholest-8-en-3β-ol
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChemSpider | |
| KEGG | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C27H46O | |
| Molar mass | 386.664 g·mol−1 |
| Appearance | crystalline solid |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
(what is ?)
Infobox references
| |
Zymostenol is an intermediate compound in the biosynthesis of cholesterol and other sterols. It is formed during the conversion of lanosterol to cholesterol, a critical metabolic pathway in animals, fungi, and some protozoa.